FGFAX
Price
$35.80
Change
+$0.24 (+0.67%)
Updated
Jan 17 closing price
Net Assets
1.12B
VTISX
Price
$134.71
Change
+$0.60 (+0.45%)
Updated
Jan 17 closing price
Net Assets
431.86B
Ad is loading...

FGFAX vs VTISX

Header iconFGFAX vs VTISX Comparison
Open Charts FGFAX vs VTISXBanner chart's image
Federated Hermes International Leaders A
Price$35.80
Change+$0.24 (+0.67%)
VolumeN/A
Net Assets1.12B
Vanguard Total Intl Stock Idx Instl Sel
Price$134.71
Change+$0.60 (+0.45%)
VolumeN/A
Net Assets431.86B
FGFAX vs VTISX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FGFAX vs. VTISX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGFAX is a Buy and VTISX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTISX has more cash in the bank: 432B vs. FGFAX (1.12B). VTISX pays higher dividends than FGFAX: VTISX (3.32) vs FGFAX (1.22). FGFAX was incepted earlier than VTISX: FGFAX (26 years) vs VTISX (9 years). FGFAX is a more actively managed with annual turnover of: 80.00 vs. VTISX (4.00). FGFAX has a lower initial minimum investment than VTISX: FGFAX (1500) vs VTISX (3000000000). VTISX annual gain was more profitable for investors over the last year : 7.06 vs. FGFAX (1.23). VTISX return over 5 years is better than : 9.66 vs. FGFAX (4.30).
FGFAXVTISXFGFAX / VTISX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years9 years-
Gain YTD1.1380.899127%
Front LoadN/AN/A-
Min. Initial Investment150030000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.12B432B0%
Annual Yield % from dividends1.223.3237%
Returns for 1 year1.237.0617%
Returns for 3 years-1.17-3.1637%
Returns for 5 years4.309.6644%
Returns for 10 years25.39N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OMER9.330.15
+1.63%
Omeros Corp
HRMY39.050.51
+1.32%
Harmony Biosciences Holdings
KTTA2.480.03
+1.22%
Pasithea Therapeutics Corp
MIST1.980.02
+1.02%
Milestone Pharmaceuticals
CCK85.560.35
+0.41%
Crown Holdings